Expertise / Research field: 

Anis Arioua holds a Doctor of Pharmacy degree, a Master's degree in the Management of Pharmaceutical Companies and Medical Technologies, and a Master's degree in Biomedical Research. He has an extensive experience in the global regulatory affairs of pharmaceuticals and medical technologies. He is currently a full-time PhD candidate at the Institute for Biomedical Ethics. 
His work focuses on beta-thalassemia - hematological condition requiring regular blood transfusions. He explores the experiences of beta-thalassemia patients and healthcare providers through empirical research, examining the burden of the disease on both groups and its impacts on their lives.

Main publications:

Peer-viewed journals:

• Anis, A. S. (2024). Use of Expired Drugs: Patients Benefits versus Industry Interest. JMA Journal, 7(1), 1-4. 10.31662/jmaj.2022-0209
• Arioua, A., & Shaw, D. (2025). The burden of thalassemia disorder: Past and present: The feedback of patients experience in the COVID-19 pandemic crisis. Asian Journal of Transfusion Science, 19(1), 125-129. 10.4103/ajts.ajts_123_23

Medical and scientific magazines:

• Les probiotiques, des aliments médicaments ? Essaydali de Tunisie, Juin 2015
• Photodynamic therapy. Essaydali magazine May 2016
• Should medication still be used after the expiry date? UniNova (UniBasel magazine) November 2024

Areas of interest: 

Ethics in Rare Diseases, Ethics and Orphan Drugs, Cell and Gene Therapy Ethics

 

CV of Anis Arioua